BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

619 related articles for article (PubMed ID: 26251402)

  • 1. Heterogeneity of peripheral blood monocytes, endothelial dysfunction and subclinical atherosclerosis in patients with systemic lupus erythematosus.
    Mikołajczyk TP; Osmenda G; Batko B; Wilk G; Krezelok M; Skiba D; Sliwa T; Pryjma JR; Guzik TJ
    Lupus; 2016 Jan; 25(1):18-27. PubMed ID: 26251402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of premature atherosclerosis in systemic lupus erythematosus patients with and without nephritis.
    Sharma SK; Rathi M; Sahoo S; Prakash M; Dhir V; Singh S
    Lupus; 2016 Apr; 25(5):525-31. PubMed ID: 26678442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subclinical atherosclerosis in systemic lupus erythematosus and antiphospholipid syndrome: focus on β2GPI-specific T cell response.
    Conti F; Spinelli FR; Alessandri C; Pacelli M; Ceccarelli F; Marocchi E; Montali A; Capozzi A; Buttari B; Profumo E; Sorice M; Arca M; Valesini G; Riganò R
    Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):661-8. PubMed ID: 24436371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High prevalence of subclinical cardiovascular abnormalities in patients with systemic lupus erythematosus in spite of a very low clinical damage index.
    Palmieri V; Migliaresi P; Orefice M; Lupo T; Di Minno MN; Valentini G; Celentano A
    Nutr Metab Cardiovasc Dis; 2009 May; 19(4):234-40. PubMed ID: 19157818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased circulating endothelial progenitor cells as an early risk factor of subclinical atherosclerosis in systemic lupus erythematosus.
    Castejon R; Jimenez-Ortiz C; Valero-Gonzalez S; Rosado S; Mellor S; Yebra-Bango M
    Rheumatology (Oxford); 2014 Apr; 53(4):631-8. PubMed ID: 24273021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced flow-mediated vasodilation as a marker for cardiovascular complications in lupus patients.
    Kiss E; Soltesz P; Der H; Kocsis Z; Tarr T; Bhattoa H; Shoenfeld Y; Szegedi G
    J Autoimmun; 2006 Dec; 27(4):211-7. PubMed ID: 17088047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subclinical atherosclerosis and endothelial dysfunction in young South-Asian patients with systemic lupus erythematosus.
    Ghosh P; Kumar A; Kumar S; Aggarwal A; Sinha N; Misra R
    Clin Rheumatol; 2009 Nov; 28(11):1259-65. PubMed ID: 19618302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of risk factors that contribute to high prevalence of premature atherosclerosis in Chinese premenopausal systemic lupus erythematosus patients.
    Zhang CY; Lu LJ; Li FH; Li HL; Gu YY; Chen SL; Bao CD
    J Clin Rheumatol; 2009 Apr; 15(3):111-6. PubMed ID: 19300290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic lupus erythematosus: an independent risk factor for endothelial dysfunction in women.
    El-Magadmi M; Bodill H; Ahmad Y; Durrington PN; Mackness M; Walker M; Bernstein RM; Bruce IN
    Circulation; 2004 Jul; 110(4):399-404. PubMed ID: 15262847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD14
    Urbanski K; Ludew D; Filip G; Filip M; Sagan A; Szczepaniak P; Grudzien G; Sadowski J; Jasiewicz-Honkisz B; Sliwa T; Kapelak B; McGinnigle E; Mikolajczyk T; Guzik TJ
    Thromb Haemost; 2017 May; 117(5):971-980. PubMed ID: 28229168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Annexin A5 as independent predictive biomarker for subclinical atherosclerosis and endothelial dysfunction in systemic lupus erythematosus patients.
    Valer P; Paul B; Eugenia B; Camelia B
    Clin Lab; 2013; 59(3-4):359-67. PubMed ID: 23724626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein-containing lipoprotein subclasses and subclinical atherosclerosis in systemic lupus erythematosus.
    Kiani AN; Fang H; Akhter E; Quiroga C; Simpson N; Alaupovic P; Magder LS; Petri M
    Arthritis Care Res (Hoboken); 2015 Mar; 67(3):442-6. PubMed ID: 25155365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Risk factors of thickened intima-media and atherosclerotic plaque development in carotid arteries in patients with systemic lupus erythematosus].
    Fischer K
    Ann Acad Med Stetin; 2008; 54(2):22-32. PubMed ID: 19374227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial cell markers reflecting endothelial cell dysfunction in patients with mixed connective tissue disease.
    Soltesz P; Bereczki D; Szodoray P; Magyar MT; Der H; Csipo I; Hajas A; Paragh G; Szegedi G; Bodolay E
    Arthritis Res Ther; 2010; 12(3):R78. PubMed ID: 20459625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired endothelial function in patients with Takayasu's arteritis.
    Alibaz-Oner F; Yurdakul S; Aytekin S; Direskeneli H
    Acta Cardiol; 2014 Feb; 69(1):45-9. PubMed ID: 24640521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Disease Duration on Vascular Surrogates of Early Atherosclerosis in Childhood-Onset Systemic Lupus Erythematosus.
    Barsalou J; Bradley TJ; Tyrrell PN; Slorach C; Ng LW; Levy DM; Silverman ED
    Arthritis Rheumatol; 2016 Jan; 68(1):237-46. PubMed ID: 26361097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of subclinical atherosclerosis by serum osteoprotegerin in premenopausal women with systemic lupus erythematous: correlation of osteoprotegerin with monocyte chemotactic protein-1.
    Park YJ; Shin YJ; Kim WU; Cho CS
    Lupus; 2014 Mar; 23(3):236-44. PubMed ID: 24531425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subclinical atherosclerosis in systemic sclerosis: Different risk profiles among patients according to clinical manifestations.
    Sciarra I; Vasile M; Carboni A; Stefanantoni K; Iannace N; Angelelli C; Scarno AG; Valesini G; Riccieri V
    Int J Rheum Dis; 2021 Apr; 24(4):502-509. PubMed ID: 33073534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A panel of biomarkers is associated with increased risk of the presence and progression of atherosclerosis in women with systemic lupus erythematosus.
    McMahon M; Skaggs BJ; Grossman JM; Sahakian L; Fitzgerald J; Wong WK; Lourenco EV; Ragavendra N; Charles-Schoeman C; Gorn A; Karpouzas GA; Taylor MB; Watson KE; Weisman MH; Wallace DJ; Hahn BH
    Arthritis Rheumatol; 2014 Jan; 66(1):130-9. PubMed ID: 24449580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiopoietin-2, endothelial dysfunction and renal involvement in patients with systemic lupus erythematosus.
    El-Banawy HS; Gaber EW; Maharem DA; Matrawy KA
    J Nephrol; 2012; 25(4):541-50. PubMed ID: 21956768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.